- If you are wondering whether Celanese's current share price reflects its true worth, this article will walk through the numbers in plain English so you can judge the value story for yourself.
- The stock recently closed at US$57.74, with returns of 17.1% over the last 7 days, a 4.7% decline over 30 days, 37.0% year to date, 1.5% over 1 year, a 41.6% decline over 3 years, and a 57.5% decline over 5 years. This gives a mixed picture for anyone thinking about risk and opportunity.
- Recent coverage around Celanese has focused on how investors are reassessing specialty chemicals companies and the pricing power of materials producers. This helps frame these uneven return figures. This background matters for valuation, because shifting expectations about the sector and capital allocation can influence how the market looks at Celanese's earnings potential and balance sheet strength.
- On our 6 point valuation checklist, Celanese scores 5 out of 6, suggesting it screens as undervalued on most of the metrics we track. Next we will walk through the key valuation approaches behind that score, then finish with a way of looking at valuation that goes beyond any single model.
Find out why Celanese's 1.5% return over the last year is lagging behind its peers.
Approach 1: Celanese Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow model takes estimates of the cash a company could generate in the future and discounts those amounts back to today, to arrive at an estimated value per share in present day dollars.
For Celanese, the latest twelve month Free Cash Flow is about $728.1 million. Analysts provide explicit Free Cash Flow estimates out to 2028, with Simply Wall St extending those forecasts further based on the same trend. In this model, projected Free Cash Flow in 2035 is $1.3b, with each year between 2026 and 2035 contributing discounted cash flows that are summed to get a total equity value.
Using this 2 Stage Free Cash Flow to Equity model, the estimated intrinsic value for Celanese is $109.49 per share. Compared with the recent share price of $57.74, the DCF output indicates an intrinsic discount of 47.3%, suggesting that the shares are trading well below this model’s estimate of value.
Result: UNDERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Celanese is undervalued by 47.3%. Track this in your watchlist or portfolio, or discover 48 more high quality undervalued stocks.
Approach 2: Celanese Price vs Sales
For companies where earnings can be noisy, the Price to Sales, or P/S, ratio is often a useful cross check because it compares the share price to the revenue the business generates, rather than to its bottom line. It is a simple way for you to see how much the market is paying for each dollar of sales.
What counts as a "normal" or "fair" P/S ratio usually reflects how fast investors expect sales to grow and how much risk they see in those future revenues. Higher expected growth and lower perceived risk tend to support a higher multiple, while weaker growth expectations or higher risk usually point to a lower one.
Celanese currently trades on a P/S ratio of 0.68x. That sits below the Chemicals industry average P/S of 1.08x and also below the peer group average of 2.84x that Simply Wall St tracks. Simply Wall St also calculates a proprietary "Fair Ratio" for Celanese of 1.38x, which is the P/S they would expect given its growth profile, margins, industry, market cap and risk factors. Because this Fair Ratio is tailored to Celanese, it can be more informative than a simple comparison with peers or the broad industry.
Comparing the current 0.68x P/S with the Fair Ratio of 1.38x points to Celanese trading below that implied range.
Result: UNDERVALUED
P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.
Upgrade Your Decision Making: Choose your Celanese Narrative
Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives. You write a simple story about Celanese that ties your view of its future revenue, earnings and margins into a forecast, compare the Fair Value that falls out of that forecast with the current share price, and then track it easily on Simply Wall St’s Community page as new news or earnings arrive. For example, one investor might build a cautious Celanese Narrative that lines up with a Fair Value near US$41 based on modest revenue trends, an 8.6% margin, a future P/E of about 7.8x and a higher discount rate. Another might prefer a more optimistic Celanese Narrative closer to US$86 that leans on revenue growth of roughly 2.2%, an 8.1% margin, a future P/E of about 15.6x and a slightly lower discount rate. Seeing both side by side can help you decide whether the current price looks high or low against the story you actually believe.
For Celanese, here are previews of two leading Celanese Narratives to make comparison easier:
Fair value: US$86.00 per share
Implied discount to this narrative: 32.9% below its fair value estimate
Revenue growth assumption: 2.25% a year
- Analysts backing this view see cost reductions, divestitures and process improvements supporting a stronger long term earnings profile and higher free cash flow resilience.
- They highlight demand for high performance polymers for electric vehicles and electronics, plus onshoring trends in North America and Europe, as positive demand drivers for Celanese's portfolio.
- This narrative assumes Celanese earns higher margins and trades on a future P/E multiple that is below the current Chemicals industry level but still supports a fair value around US$86.
Fair value: US$41.00 per share
Implied premium to this narrative: 40.8% above its fair value estimate
Revenue growth assumption: 0.54% decline a year
- The bearish view focuses on structural demand pressure, oversupply and tighter regulation, which together could weigh on profitability and leave some assets underused.
- High leverage, interest costs and ongoing spending on technology and compliance are seen as constraints on financial flexibility and potential upside.
- On these assumptions, analysts backing this case see a lower long term revenue trend, a modest margin improvement and a future P/E closer to 7.8x, which feeds into a fair value of about US$41.
Considering both narratives side by side can help you assess which set of assumptions aligns more closely with your own view on Celanese's end markets, balance sheet and earnings potential.
Curious how numbers become stories that shape markets? Explore Community Narratives
Do you think there's more to the story for Celanese? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com